°²öÎÓéÀÖ¹ÙÍø

°²öÎÓéÀÖ¹ÙÍøÑÛ¿Æ
Ä¿½ñλÖ㺠Ê×Ò³ > ¾ÍÕïÖ¸ÄÏ > ³£¼ûÑÛ²¡ÐÂÎÅ > ÕýÎÄ

µÑÕ븺ѹÎüÒý¸¨ÖúÁѿױպÏÊÖÒÕÒ½ÖδóÌØ·¢ÐԻưßÁÑ¿× Ñо¿

×÷ÕߣºÎ´Öª 2019-01-31 13:07:19
×ÖÌå´óС£º
¡¾µ¼¶Á¡¿µÑÕ븺ѹÎüÒý¸¨ÖúÁѿױպÏÊÖÒÕÒ½ÖδóÌØ·¢ÐԻưßÁÑ¿× Ñо¿

¡¡¡¡»Æ°ßÁѿ׵ľÞϸ¶ÔÁÑ¿×ÓúºÏÓнϴóÓ°Ïì¡£2013Äê¾ÙÊÀ²£Á§Ì廯°ßÇ£ÒýС×齫OCT²â¶¨µÄ>400 ¦ÌmÕß³ÆÎª´óÁÑ¿× £¬²¿·ÖÑо¿ÕßʵÑé½ÓÄÉÄÚ½çĤ°ê·­×ªÊÖÒÕ¶Ô´óIMH¾ÙÐÐÒ½ÖÎÒÔ̽ÌÖÊÇ·ñ¿ÉÌá*ÊÖÊõ ÂÊ £¬³ÉΪ½üÄêÀ´»Æ°ßÁÑ¿×ÊÖÊõµÄÑо¿ÈÈÃÅ¡£

¡¡¡¡ÄÚ½çĤ°ê·­×ªÊõÊǽâ¾ö´óIMHµÄ Ñ¡Ôñô?±¾Ñо¿ÖÐͨ¹ýÄÚ½çĤ°þ³ýÍŽáµÑÕ븺ѹÎüÒý¸¨ÖúÁѿױպÏÊÖÒÕÒ½ÖÎ408 - 939 ¦ÌmµÄIMH £¬·¢Ã÷¸ÃÒªÁì¿ÉʹÁÑ¿×ÏòÐÄÐÔËõС £¬´Ó¶øÐÞ¸´Áѿס£±¾Ñо¿ÖÐËùÓл¼ÕßÊõºóÁѿ׾ù³ÊUÐͺÍVÐÍÓúºÏ £¬ÎÞ3ÐͺÍ4ÐÍÓúºÏÕß¡£Ñо¿·¢Ã÷ £¬4ÐÍÓúºÏÕß¾Ö²¿RPEϸ°ûÍâòÉñ¾­ÊÓÍøÄ¤²ãȱÈç £¬¹ÊÊõºóÊÓÁ¦½Ï²î¡£ÓÐÑо¿Åú×¢ £¬IMHÊõºó4ÐÍÓúºÏÕß±È Îª10% - 20%¡£±¾×黼ÑÛÊ×´ÎÊõºóÁÑ¿×δ±ÕºÏÕßÕ¼25% £¬ÓÉÓÚÏÖÔÚ³¤Ð§ÆøÌåȱ·¦ £¬¹ÊÁÑ¿×Êõºóδ±ÕÊÊʱÐèʵʱÐв£Á§ÌåÄÚÎÞ¾ú¿ÕÆø×¢Éä £¬Ò½ÖκóÁѿ׾ù±ÕºÏ¡£ËµÃ÷ËäÈ»²£Á§ÌåÇиîÍŽá¿ÕÆøÌî³ä¿Éʹ´óIMHÓúºÏ £¬µ«¿ÕÆø³äÌîµÄÒ½ÖÎ ¿ÉÄܲ»Èç³¤Ð§ÆøÌå £¬Í¬Ê±Ö¤ÊµÒ½ÖδóIMH²¢²»ÐèÒª¾ÙÐкã¾Ã²£Á§ÌåÄÚ¹èÓÍÌî³ä¡£

¡¡¡¡ÖµµÃ×¢ÖØµÄÊÇ £¬Áѿ׾Þϸ²¢·ÇÊÇÓ°ÏìÊ×´ÎÊÖÊõ ÂÊµÄ Ôµ¹ÊÔ­ÓÉ £¬ÄÚ½çĤ°þ³ýÊõµÄ¼¼ÇÉÒ²ÊÇÊÖÊõ³É°ÜµÄÒªº¦¡£ÓÐȤµÄÊÇ £¬PangµÈÔÚÊÓÍøÄ¤È«²ãÁÑ¿×Öз¢Ã÷Óлư߰å²ãÁÑ¿×Ïà¹ØµÄÊÓÍøÄ¤Ç°Ä¤ÔöÉú(lamellar hole-associated epiretinal proliferation, LHEP)¡£LHEPÊÇÊÓÍøÄ¤°å²ãÁÑ¿×ÍâòµÄ¡¢µ«²»Ç£À­ÊÓÍøÄ¤µÄÒ»ÖÖËðÉËÐÞ¸´×éÖ¯ £¬¿ÉÔö½ø»Æ°ßÁÑ¿×ÓúºÏ¡£LHEPÔ´×ÔÁѿ״¦ÊÓÍøÄ¤µÄÖÐÐIJã £¬ÑØ×é֯ȱËð²¿Î»¾­ÁÑ¿×ÔµÔöÉúÖÁÊÓÍøÄ¤Äڲ㠣¬ÊÖÊõÖÐÄÚ½çĤµÄÏòÐÄÐÔ°þ³ý¿ÉºÜºÃµØ± £»¤LHEP £¬ÓÐÖúÓÚÁѿױßÑØµÄËɽâ £¬´Ó¶øÊ¹ÁѿױպÏ¡£

¡¡¡¡ÄÚ½çĤ°ê·­×ªÊõºóÊÓÍøÄ¤Íâ²ã×éÖ¯µÄÐÞ¸´ÊÇ·ñÀûÓÚÊÓÍøÄ¤µÄ¹¦Ð§  £¬´Ó¶ø¸üºÃµØ »Æ°ßÇøÊÓ¹¦Ð§ÏÖÔÚ±¨µÀ½ÏÉÙ £¬±ðµÄÒ²ÉÐȱ·¦¶ÔÄÚ½çĤ°ê·­×ªÊõÓëÄÚ½çĤ°þ³ýÊõÊõºóÊÓ¹¦Ð§Ð§¹û¾ÙÐнÏÁ¿µÄÎÄÏ××ÊÁÏ¡£PakµÈÑо¿·¢Ã÷ £¬ÄÚ½çĤ°ê·­×ªÊõºó²¢Î´ÊӲ쵽ÏÔ×ŵÄÊÓÍøÄ¤ELM¼°EZµÄÐÞ¸´¡£±¾Ñо¿ÖнÓÄɵÑÕ븨ÖúµÄÁѿױպÏÊÖÒÕ £¬ÊõÖпÉÊÓ²ìÁѿ׵ÄËõСºÍ±ÕºÏ £¬ÊõºóÔçÆÚ¾Í¿ÉÒÔÊӲ쵽ELMºÍEZȱËð¹æÄ£µÄËõС £¬ÊõºóÊÓÁ¦ÏÔ×ÅÌá* £¬ÌáÐѸÃÊõʽÓÐÖúÓڻư߹¦Ð§µÄ ¡£

ÔÚÏß×Éѯ
·µ»Ø
?
  • »ª±±µØÇø
  • »ªÄϵØÇø
  • Î÷ÄϵØÇø
  • »ªÖеØÇø
  • »ª¶«µØÇø
  • Î÷±±µØÇø
  • ¶«±±µØÇø
°²öÎÓéÀÖ¹ÙÍøÑÛ¿ÆÎ¢ÐŹ«ÖںŠ΢ÐŹ«ÖÚºÅ
΢²©
ÍøÕ¾µØÍ¼